Yes, B12, RSV, Flu, and Prevnar can be given at the same time
All four agents—vitamin B12 injection, RSV vaccine, influenza vaccine, and Prevnar (pneumococcal conjugate vaccine)—can be safely administered concomitantly at the same visit. The vaccines should be given with different syringes at different anatomic sites, preferably in different limbs when feasible.
Evidence-Based Rationale
Vaccine Co-administration is Supported by Guidelines
The most recent 2026 Taiwan pneumococcal vaccination guidelines provide strong evidence that pneumococcal vaccines can be administered concomitantly with seasonal influenza vaccines (Strong recommendation, moderate quality of evidence) 1. The guidelines explicitly state that "in general, inactivated vaccines can be administered concomitantly with other inactivated or live attenuated vaccines" 1.
For RSV vaccines specifically, the 2024 CDC ACIP guidance confirms that "administration of RSV vaccine with other adult vaccines during the same visit is acceptable" 2. The 2024-25 influenza ACIP recommendations similarly support concomitant administration, noting that vaccines can be given simultaneously as long as they are administered at separate anatomic sites 3.
Practical Administration Guidelines
When administering these vaccines together:
- Use separate syringes for each vaccine
- Administer at different injection sites
- Consider using different limbs when possible, especially for vaccines more likely to cause local reactions 1
- Do not mix any vaccines in the same syringe 4
Vitamin B12 (cyanocobalamin) injection is not a vaccine and has no contraindications to concurrent administration with vaccines. It can be given at a separate site without concern for interference.
Safety Profile
Multiple randomized controlled trials demonstrate that pneumococcal and influenza vaccines administered concomitantly are safe and well-tolerated 1. While some studies report slightly higher rates of mild adverse effects with concomitant vaccination compared to separate administration, no serious safety concerns have been identified 1.
A 2023 Chinese study of 2,461 adults aged ≥60 years who received simultaneous influenza and pneumococcal vaccines found an overall adverse reaction rate of only 2.07%, primarily Grade 1 reactions, with no serious adverse events 5.
Important Caveats
Immunogenicity considerations: While concomitant administration is safe, some studies show slightly lower antibody responses for certain pneumococcal serotypes when vaccines are co-administered 1, 6. However, the clinical significance remains unclear, and the benefits of improved vaccination coverage generally outweigh these modest immunologic differences 7, 8.
Adjuvanted vaccines: If using adjuvanted influenza vaccine (like Fluad) or adjuvanted RSV vaccine (like Arexvy), be aware that reactogenicity may be higher when multiple adjuvanted vaccines are given together 3. Consider using a non-adjuvanted option if multiple vaccines are being administered, though vaccination should not be delayed if a specific formulation is unavailable.
Patient counseling: Inform patients that they may experience more injection site reactions when receiving multiple vaccines simultaneously, but this does not indicate reduced safety or efficacy.